Patent Assignment
Reel/Frame 053561/0070
Release of Security Interest
Recorded: 2020-08-20
Pages: 27
Assignor
MIDCAP FINANCIAL TRUST, AS AGENT
Executed: 2020-08-13
Assignees
OLOGY BIOSERVICES, INC.
13200 NW NANO CT, ALACHUA, FLORIDA, 32615
NANO ADM, LLC
13859 PROGRESS BLVD., SUITE 300, ALACHUA, FLORIDA, 32615
Covered Properties
(43)
Norovirus Vaccine
PCT:
PCT/US2016/048940 ↗
Method of Inactivating Lipid-Enveloped Viruses
Patent:
6,136,321 →
Application:
09/021,146 →
Aloe Pectins
Patent:
5,929,051 →
Application:
09/078,204 →
Pharmaceutical Compositions Comprising Pectins Having High Molecular Weighs and Low Degrees of Methoxylation
Patent:
7,022,683 →
Application:
09/325,610 →
Pectic Substance as a Growth Factor Stabilizer
Patent:
6,274,548 →
Application:
09/325,923 →
In-Situ Gel Formation of Pectin
Inactivated Influenza Virus Vaccine for Nasal or Oral Application
Patent:
6,635,246 →
Application:
09/913,400 →
Enveloped Virus Vaccine and Method for Production
Method for Large Scale Production of Virus Antigen
High Molecular Weight, Low Methoxyl Pectins, and Their Production and Uses
Inactivated Influenza Virus Vaccine for Nasal or Oral Application
Delivery of Physiological Agents with in-Situ Gels Comprising Anionic Polysaccharides
Inactivated Influenza Virus Vaccine for Nasal or Oral Application
Large Scale Productions of Virus Antigen
Inactivation of a pathogen in a sample by a treatment with formalin and UV light
Two-Step Temperature Profile for the Propagation of Viruses
Method for Producing Viral Vaccines
Vaccine Formulations and Uses Thereof
Method for Producing Continuous Cell Lines
Medium Supplement for Virus Production
METHOD FOR PRODUCTION OF pH STABLE ENVELOPED VIRUSES
Novel Method for Generation of Rna Virus
Production of Viral Vaccine
Linear Expression Constructs for Production of Influenza Virus Particles
Application:
12/666,459 →
Publication:
US 2010/0129399
Modified Influenza Virus
METHOD FOR PRODUCTION OF pH STABLE ENVELOPED VIRUSES
Novel Method for Generation of Rna Virus
High Growth Reassortant Influenza a Virus
Vaccine Formulations and Uses Thereof
Novel Influenza Virus
Methods for Isolating and Quantifying Antigen from Vaccines
Recombinant Viral Vectors and Methods for Inducing a Heterosubtypic Immune Response to Influenza a Viruses
Replication Deficient Influenza Virus for the Expression of Heterologous Sequences
Enveloped Virus Vaccine and Method for Production
Application:
14/264,925 →
Publication:
US 2016/0199478
Method for Producing Continuous Cell Lines
Method for Influenza Virus Purification
Method for Producing Continuous Cell Lines
Application:
15/206,849 →
Publication:
US 2016/0376552
Recombinant Viral Vectors and Methods for Inducing a Heterosubtypic Immune Response to Influenza a Viruses
Novel Influenza Virus
Application:
15/655,306 →
Publication:
US 2018/0016560
Norovirus Vaccine
Application:
15/754,807 →
Publication:
US 2018/0243397
Method for Producing Continuous Cell Lines
Application:
16/018,435 →
Publication:
US 2018/0298327
Method for Virus Production
Application:
62/806,277 →
Method for Cultivation of Adherent Cells in a Multiparallel Bioreactor
Application:
62/869,050 →
Related Assignments
(18)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jan 15, 2010
From: DELSITE, INC.
To: NANOTHERAPEUTICS, INC.
Reel/Frame 023796/0607 →
Security Interest
Mar 20, 2015
From: NANOTHERAPEUTICS, INC.
To: WHITE OAK GLOBAL ADVISORS, LLC
Reel/Frame 035236/0932 →
Assignment of Assignor's Interest
Aug 18, 2015
From: BAXTER HEALTHCARE SA
To: BAXALTA GMBH
Reel/Frame 036388/0729 →
Assignment of Assignor's Interest
Aug 18, 2015
From: BAXTER HEALTHCARE SA
To: BAXALTA GMBH
Reel/Frame 036388/0070 →
Assignment of Assignor's Interest
Aug 28, 2015
From: BAXTER INTERNATIONAL INC.
To: BAXALTA GMBH
Reel/Frame 036502/0752 →
Assignment of Assignor's Interest
Nov 24, 2015
From: BAXALTA GMBH
To: NANOTHERAPEUTICS, INC.
Reel/Frame 037155/0732 →
Corrective Assignment to Correct the Correspondence Data Previously Recorded on Reel 037155 Frame 0732. Assignor(S) Hereby Confirms the Assignment.
May 2, 2016
From: BAXALTA GMBH
To: NANOTHERAPEUTICS, INC.
Reel/Frame 038592/0044 →
Release of Security Interest
May 19, 2016
From: WHITE OAK GLOBAL ADVISORS, LLC AS AGENT
To: NANOTHERAPEUTICS, INC.
Reel/Frame 038651/0947 →
Patent Assignment Recordation Statement
Aug 31, 2016
From: BAXALTA GMBH
To: NANOTHERAPEUTICS, INC.
Reel/Frame 039894/0181 →
Patent Assignment Recordation Statement
Aug 31, 2016
From: BAXTER HEALTHCARE SA
To: BAXALTA GMBH
Reel/Frame 039889/0224 →
Security Interest
May 1, 2018
From: OLOGY BIOSERVICES, INC.
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 046050/0305 →
Change of Name
Jan 23, 2019
From: NANOTHERAPEUTICS, INC.
To: OLOGY BIOSERVICES, INC.
Reel/Frame 049518/0666 →
Change of Name
Jan 23, 2019
From: NANOTHERAPEUTICS, INC.
To: OLOGY BIOSERVICES, INC.
Reel/Frame 048117/0275 →
Security Interest Supplement
Jun 12, 2020
From: OLOGY BIOSERVICES, INC.; MAMO ADM, LLC
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 052927/0061 →
Change of Name
Sep 8, 2022
From: OLOGY BIOSERVICES, INC.
To: RESILIENCE GOVERNMENT SERVICES, INC.
Reel/Frame 061399/0903 →
Assignment of Assignor's Interest
Sep 16, 2022
From: COBB, RON; SPRINGER, MICHAEL; NI, YAWEI
To: OLOGY BIOSERVICES, INC.
Reel/Frame 061126/0807 →
Change of Name
Sep 19, 2022
From: OLOGY BIOSERVICES, INC.
To: RESILIENCE GOVERNMENT SERVICES, INC.
Reel/Frame 061463/0688 →
Change of Name
Nov 20, 2025
From: RESILIENCE GOVERNMENT SERVICES, INC,
To: ALACHUA GOVERNMENT SERVICES, INC.
Reel/Frame 073279/0021 →